Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STAR-TEER Ⅰ: Antithrombotic Strategies After TEER in Patients Needing OAC
NCT06901466Phase 4Recruiting
- Sponsor
- Chinese Academy of Medical Sciences
- Start
- Jun 2025
- Primary completion
- Oct 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of rivaroxaban, clopidogrel in mitral regurgitation (MR), Atrial fibrillation (AFib), sponsored by Chinese Academy of Medical Sciences. Started Jun 2025; status: recruiting.
02
Drugs
rivaroxabanclopidogrel
03
Conditions
mitral regurgitation (MR)Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT06901466.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06901466.